Potassium guaiacolsulfonate

DB13735

small molecule approved experimental

Deskripsi

Guaiacolsulfonate is an aromatic sulfonic acid. Potassium guaiacolsulfonate salt is an expectorant that thins the mucus in the lungs and reduces chest congestion.

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

286 Data
Ramipril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Ramipril.
Fosinopril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Fosinopril.
Trandolapril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Trandolapril.
Benazepril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Benazepril.
Enalapril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Enalapril.
Moexipril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Moexipril.
Lisinopril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Lisinopril.
Perindopril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Perindopril.
Quinapril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Quinapril.
Omapatrilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Omapatrilat.
Rescinnamine The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Rescinnamine.
Captopril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Captopril.
Cilazapril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Cilazapril.
Spirapril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Spirapril.
Temocapril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Temocapril.
Enalaprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Enalaprilat.
Imidapril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Imidapril.
Zofenopril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Zofenopril.
Delapril The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Delapril.
Benazeprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Benazeprilat.
Fosinoprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Fosinoprilat.
Ramiprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Ramiprilat.
Trandolaprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Trandolaprilat.
Moexiprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Moexiprilat.
Perindoprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Perindoprilat.
Quinaprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Quinaprilat.
Cilazaprilat The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Cilazaprilat.
Triamterene The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Triamterene.
Spironolactone The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Spironolactone.
Amiloride The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Amiloride.
Eplerenone The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Eplerenone.
Canrenoic acid The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Canrenoic acid.
Canrenone The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Canrenone.
Valsartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Valsartan.
Olmesartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Olmesartan.
Losartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Losartan.
Candesartan cilexetil Potassium guaiacolsulfonate may increase the hyperkalemic activities of Candesartan cilexetil.
Eprosartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Eprosartan.
Telmisartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Telmisartan.
Irbesartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Irbesartan.
Forasartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Forasartan.
Saprisartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Saprisartan.
Tasosartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Tasosartan.
Saralasin Potassium guaiacolsulfonate may increase the hyperkalemic activities of Saralasin.
Azilsartan medoxomil Potassium guaiacolsulfonate may increase the hyperkalemic activities of Azilsartan medoxomil.
Fimasartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Fimasartan.
Candesartan Potassium guaiacolsulfonate may increase the hyperkalemic activities of Candesartan.
Cyclosporine Potassium guaiacolsulfonate may increase the hyperkalemic activities of Cyclosporine.
Icosapent Potassium guaiacolsulfonate may increase the hyperkalemic activities of Icosapent.
Esmolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Esmolol.
Betaxolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Betaxolol.
Fluconazole Potassium guaiacolsulfonate may increase the hyperkalemic activities of Fluconazole.
Succinylcholine Potassium guaiacolsulfonate may increase the hyperkalemic activities of Succinylcholine.
Mesalazine Potassium guaiacolsulfonate may increase the hyperkalemic activities of Mesalazine.
Metoprolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Metoprolol.
Indomethacin Potassium guaiacolsulfonate may increase the hyperkalemic activities of Indomethacin.
Atenolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Atenolol.
Timolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Timolol.
Digoxin Potassium guaiacolsulfonate may increase the hyperkalemic activities of Digoxin.
Ardeparin Potassium guaiacolsulfonate may increase the hyperkalemic activities of Ardeparin.
Trimethoprim Potassium guaiacolsulfonate may increase the hyperkalemic activities of Trimethoprim.
Nabumetone Potassium guaiacolsulfonate may increase the hyperkalemic activities of Nabumetone.
Ketorolac Potassium guaiacolsulfonate may increase the hyperkalemic activities of Ketorolac.
Tenoxicam Potassium guaiacolsulfonate may increase the hyperkalemic activities of Tenoxicam.
Celecoxib Potassium guaiacolsulfonate may increase the hyperkalemic activities of Celecoxib.
Sotalol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Sotalol.
Tolmetin Potassium guaiacolsulfonate may increase the hyperkalemic activities of Tolmetin.
Rofecoxib Potassium guaiacolsulfonate may increase the hyperkalemic activities of Rofecoxib.
Piroxicam Potassium guaiacolsulfonate may increase the hyperkalemic activities of Piroxicam.
Propranolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Propranolol.
Fenoprofen Potassium guaiacolsulfonate may increase the hyperkalemic activities of Fenoprofen.
Valdecoxib Potassium guaiacolsulfonate may increase the hyperkalemic activities of Valdecoxib.
Diclofenac Potassium guaiacolsulfonate may increase the hyperkalemic activities of Diclofenac.
Labetalol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Labetalol.
Sulindac Potassium guaiacolsulfonate may increase the hyperkalemic activities of Sulindac.
Bisoprolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Bisoprolol.
Nitrofurantoin Potassium guaiacolsulfonate may increase the hyperkalemic activities of Nitrofurantoin.
Flurbiprofen Potassium guaiacolsulfonate may increase the hyperkalemic activities of Flurbiprofen.
Pentamidine Potassium guaiacolsulfonate may increase the hyperkalemic activities of Pentamidine.
Etodolac Potassium guaiacolsulfonate may increase the hyperkalemic activities of Etodolac.
Potassium chloride Potassium guaiacolsulfonate may increase the hyperkalemic activities of Potassium chloride.
Mefenamic acid Potassium guaiacolsulfonate may increase the hyperkalemic activities of Mefenamic acid.
Naproxen Potassium guaiacolsulfonate may increase the hyperkalemic activities of Naproxen.
Sulfasalazine Potassium guaiacolsulfonate may increase the hyperkalemic activities of Sulfasalazine.
Phenylbutazone Potassium guaiacolsulfonate may increase the hyperkalemic activities of Phenylbutazone.
Meloxicam Potassium guaiacolsulfonate may increase the hyperkalemic activities of Meloxicam.
Carprofen Potassium guaiacolsulfonate may increase the hyperkalemic activities of Carprofen.
Diflunisal Potassium guaiacolsulfonate may increase the hyperkalemic activities of Diflunisal.
Tacrolimus Potassium guaiacolsulfonate may increase the hyperkalemic activities of Tacrolimus.
Alprenolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Alprenolol.
Meclofenamic acid Potassium guaiacolsulfonate may increase the hyperkalemic activities of Meclofenamic acid.
Acetylsalicylic acid Potassium guaiacolsulfonate may increase the hyperkalemic activities of Acetylsalicylic acid.
Pindolol Potassium guaiacolsulfonate may increase the hyperkalemic activities of Pindolol.
Oxaprozin Potassium guaiacolsulfonate may increase the hyperkalemic activities of Oxaprozin.
Ketoprofen Potassium guaiacolsulfonate may increase the hyperkalemic activities of Ketoprofen.
Balsalazide Potassium guaiacolsulfonate may increase the hyperkalemic activities of Balsalazide.
Sulfamethoxazole Potassium guaiacolsulfonate may increase the hyperkalemic activities of Sulfamethoxazole.
Ketoconazole Potassium guaiacolsulfonate may increase the hyperkalemic activities of Ketoconazole.
Ibuprofen Potassium guaiacolsulfonate may increase the hyperkalemic activities of Ibuprofen.
Heparin Potassium guaiacolsulfonate may increase the hyperkalemic activities of Heparin.

Contoh Produk & Brand

Produk: 10 • International brands: 0
Produk
  • Ambenyl Cough Syrup
    Liquid • - • Oral • Canada • Approved
  • P-Tuss
    Liquid • - • Oral • US
  • Phenergan Expectorant Syr
    Syrup • - • Oral • Canada • OTC • Approved
  • Phenergan Expectorant With Codeine Liq
    Liquid • - • Oral • Canada • Approved
  • Phenergan Expectorant With Codeine Liquid
    Liquid • - • Oral • Canada • Approved
  • Phenergan Vc Expectorant Syr
    Syrup • - • Oral • Canada • OTC • Approved
  • Phenergan Vc Expectorant W Codeine Liq
    Liquid • - • Oral • Canada • Approved
  • Phenylephrine Carbetapentane Potassium Guaiacolsulfonate
    Liquid • - • Oral • US
Menampilkan 8 dari 10 produk.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul